AMT Stock Recent News

AMT's Q1 results reflect a year-over-year rise in revenues, led by property and service operations segment revenues. Strong organic tenant billing growth aids results.

While the top- and bottom-line numbers for American Tower (AMT) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

American Tower Corporation (NYSE:AMT ) Q1 2025 Earnings Conference Call April 29, 2025 8:30 AM ET Company Participants Adam Smith - Senior Vice President, Investor Relations and FP&A Steve Vondran - President & Chief Executive Officer Rod Smith - Executive Vice President, Chief Financial Officer & Treasurer Conference Call Participants Matt Niknam - Deutsche Bank Jim Schneider - Goldman Sachs Ric Prentiss - Raymond James & Associates Michael Rollins - Citi Nick Del Deo - Moffett Nathanson Batya Levi - UBS Eric Luebchow - Wells Fargo Michael Funk - Bank of America Ben Swinburne - Morgan Stanley Jonathan Atkin - RBC Capital Markets Operator Ladies and gentlemen, thank you for standing by. Welcome to the American Tower First Quarter 2025 Earnings Conference Call.

Welltower Inc. outperformed due to its strong senior housing portfolio, cyclical and secular growth prospects, and strategic acquisition of Amica. American Tower Corporation showed solid performance driven by carrier bookings and a positive 2025 outlook post its exit from India. Equinix, Inc. and Digital Realty Trust, Inc. underperformed due to valuation normalization, earnings headwinds, and evolving concerns in the data center sector.

Wireless infrastructure provider American Tower on Tuesday beat the first-quarter revenue estimate, driven by steady demand for its leasing business.

BOSTON--(BUSINESS WIRE)--American Tower Corporation (NYSE: AMT) today reported financial results for the quarter ended March 31, 2025. Steven Vondran, American Tower's Chief Executive Officer, stated, “The solid leasing trends we saw over the course of 2024 carried into the first quarter, with sustained demand across our global portfolio. In the U.S., accelerating broad-based mid-band deployments and the early indications of capacity-driven new site demand supported our highest quarter of servi.

American Tower (AMT) is favored over Crown Castle (CCI) due to a better balance sheet, and stronger FFO growth relative to price growth. CCI's higher dividend yield is unsustainable, with a significant cut expected, reducing its attractiveness compared to AMT's stable dividend. AMT's growth is funded by debt, avoiding the dilution issues plaguing CCI, which faces operational challenges and divestitures.

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for American Tower (AMT), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2025.

REITs finished the first quarter of 2025 in the red (-3.36%) with a brutal -4.92% average total return in March. Large cap (-2.04%) and mid cap REITs (-2.63%) saw modest losses, but small caps (-4.16%) and micro caps (-16.19%) had a particularly bad month. Only 29.49% of REIT securities had a positive total return in March.

uniQure's AMT-130 gene therapy for Huntington's Disease shows promising trial data, leading to significant stock price increases and potential for FDA accelerated approval. QURE's stock has seen volatility but has near-term catalysts like BLA submission and 36-month trial data, suggesting potential for immediate further gains. Despite competition from PTC518, AMT-130's effectiveness and one-time treatment advantage could drive substantial revenue and stock price growth.